Concord
HR 679 · 119th Congress

To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.

This bill hasn't been enriched yet — fetch cosponsors, actions, subjects, titles, and summaries from Congress.gov.
Why?

Every bill carries a core record (title, sponsor, latest action) that Concord fetches up front. The detailed sections — cosponsors, action history, subjects, titles, and summaries — live behind separate Congress.gov endpoints, so they're fetched on demand rather than for all 50,000+ bills at once. Until a bill has been enriched, those sections stay empty.

Brief

Executive summary AI-generated

No executive summary yet — generate one to distill the facts below into a few sentences.

Sponsor
Diana Harshbarger
Policy area
Health
Introduced
2025-01-23
Chamber
House
Status
2025-01-23 — Referred to the House Committee on Energy and Commerce.
Coalition
0 cosponsors (0 original)
0 actions on file 0 recorded votes
No CRS summary available for this bill.
Generating…

Latest action

2025-01-23 — Referred to the House Committee on Energy and Commerce.

Summaries

Summaries not yet fetched.

Sponsor

Diana Harshbarger

Cosponsors

Cosponsors not yet fetched.

Vote history

No votes recorded for this bill yet.

Action history

Action history not yet fetched.

Subjects

Subjects not yet fetched.

Titles

Titles not yet fetched.